Therwil, Switzerland

Daniel Bur

USPTO Granted Patents = 29 

 

 

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 114(Granted Patents)


Location History:

  • Basel, CH (2000 - 2001)
  • CH-4106 Therwil, CH (2010)
  • Allschwil, CH (2010 - 2019)
  • Therwil, CH (2003 - 2022)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: Daniel Bur: A Prolific Inventor in the Field of Pharmaceutical Science

Introduction:

Daniel Bur, a resident of Therwil, Switzerland, is an accomplished inventor and pharmaceutical researcher with an impressive portfolio of patents. His inventive contributions have centered around the development of novel compounds and their applications in the field of medicine, particularly in cancer treatment. This article will provide an overview of his latest patents, career highlights, notable collaborations, and a conclusion highlighting his significant contributions to the pharmaceutical industry.

Latest Patents:

Daniel Bur has successfully obtained 27 patents throughout his career, making him a highly respected figure in the field of pharmaceutical science. Two of his most recent inventions include:

1. Inhibitors of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO):

The patent focuses on compounds designed to inhibit IDO and/or TDO enzymes. These enzymes are known to play a vital role in cancer development and progression. The compounds, belonging to Formula (I), have been demonstrated to have potential therapeutic applications in cancer treatment.

2. Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase (TPH):

This patent highlights the development of tricyclic imidazole compounds (Formula I) as inhibitors of TPH. TPH is an enzyme involved in serotonin synthesis and has implications in various psychiatric disorders. The invention presents potential applications in the modulation of TPH as a therapeutic approach for managing related conditions.

Career Highlights:

Daniel Bur has made significant contributions to the pharmaceutical industry through his work at reputable companies. He has worked at Actelion Pharmaceuticals Ltd and Hoffmann-La Roche Inc. (Roche), two influential players in the field of pharmaceutical research and development. Bur's work within these organizations has contributed to advancements in drug discovery and innovation.

Collaborations:

Throughout his career, Daniel Bur has collaborated with esteemed professionals in the field. Some of his notable collaborators include Corinna Grisostomi and Sylvia Richard-Bildstein. These collaborations have fostered an environment of knowledge exchange, innovation, and the potential for groundbreaking discoveries.

Conclusion:

Daniel Bur's impressive portfolio of 27 patents is a testament to his dedication and groundbreaking contributions to the pharmaceutical industry. Through his inventive work, he has focused on developing compounds with potential therapeutic applications in cancer treatment and psychiatric disorders. Collaborating with esteemed professionals and working for renowned pharmaceutical companies has further enhanced his career trajectory. Bur's innovative mindset and commitment to scientific advancement continue to inspire and shape the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…